Figure 3.
Protein network by MetaCore built with the differential proteins found (blue spheres) adding FGFR1, VEGFR-1, PDGF receptor, known to be targets of the Nintedanib treatment. PDGF-R-beta, FGFR1, VEGFR-1, HP, PDGF receptor result central hubs. Green edges indicate «induction», red edges are correlated with inhibition, while grey edges indicate an unspecified effect. Bold light blue line represent well-known canonical pathways.